India’s mobile sector sustained mid-teen growth again, though we expect a slowdown to high single digits from 2QFY25 onwards once last July’s tariff increase is lapped. Margin expansion remains a theme too. We stay constructive on India with Bharti Airtel as our preferred pick, but would continue to see Singtel as having more upside.
With sentiment, leverage and cash flow all improving for EM Telcos we think we are approaching the point of the cycle where M&A is going to become more prevalent, and shift from bearish (in-market consolidation), to bullish (out of footprint). Investors should consider building portfolios based on likely targets. Who are they?
It was another very strong month for our picks as the EM Telco bull market continues. As we have been arguing for some time EM Telco is a much better space than it used to be, and the market has now started to understand this. This note also includes key news & other thoughts, to try to help investors generate alpha within the EM Telco space.
Following our day spent with Millicom in Miami and Q1 results we review our model. Assuming the Colombian deal closes we now see the company on a path to $1bn EFCF once synergies are delivered. Dividends are likely to rise to over $4/share, driving the shares towards $50. We remain Buyers and upgrade our price target to US$46.
In today's Morning Views publication we comment on developments of the following high yield issuers: YPF, Falabella, Geopark, Canacol, Cencosud, TGS, Millicom, Klabin, C&W Communications, Movida, GOL, Orbia, Minerva, Suzano, Rumo, Investment Energy Resources, Simpar, Ultrapar
We analyze the capex history & outlook for Global EM Telcos. For this group capex is falling rapidly (-12% in 2024 in US$) as competitive intensity improves and markets consolidate. Excluding China and India, EM Telco capex is already down 23% from peak.
Reliance Industries closed off FY25 with strong Retail and O2C topline growth, alongside continued strength in Jio’s profitability. The company has also proposed a INR 5.5 dividend per share, which was in-line with expectations.
GREATER CHINA Results Aier Eye Hospital Group (300015 CH/BUY/Rmb12.72/Target: Rmb17.80) 2024: Satisfactory results; expects strong recovery in 2025. Upgrade to BUY. Ningbo Tuopu Group Co (601689 CH/BUY/Rmb50.96/Target: Rmb83.00) 4Q24: Earnings up 38.5% yoy, in line. Maintain BUY with target price unchanged at Rmb83.00. TAL Educational Group (TAL US/BUY/US$9.36/Target: US$14.00) 4QFY25: Earnings miss amid ramped-up investments in AI-powered learning. INDONESIA Sector Telecommun...
In the latest edition of our LatAm Trade Book, we review most of our current trade recommendations. We also discuss key metrics of the issuers and how the bonds fare relative to peers. Please reach out to our analysts to discuss any of these ideas, or other trade recommendations from our LatAm coverage.
A director at Indosat Tbk Pt bought 300,000 shares at 1,520.000IDR and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Perhaps the biggest surprise from last night’s White House announcement was the scale of tariffs imposed on Asian exporters (and South Africa). Being an ally of America provided no benefit with Thailand (36%) facing higher tariffs than China (34%). By contrast, Latin America and Sub-Saharan Africa are less negatively impacted, and may even benefit overall from dollar weakness. We run through likely implications for our coverage in Global EM and Japan. Spoiler alert: we see Rakuten as most negati...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.